Murray Hill, NJ -- November 15, 2001 -- C. R. Bard, Inc. (NYSE-BCR) filed its Quarterly Report on Form 10-Q with the Securities and Exchange Commission yesterday in which it disclosed that its proposed merger with a subsidiary of Tyco International Ltd. is now not expected to close before the first quarter of 2002. The company noted that discussions with the U.S. Federal Trade Commission regarding this merger are ongoing at this time.

Both the managements of C. R. Bard and Tyco International remain fully committed to the completion of this transaction.

C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill, New Jersey, is a leading multinational developer, manufacturer and marketer of health care products in the fields of vascular, urology, oncology and surgical specialty products.